
Gamma-amino butyric acid (GABA) is an inhibitory neurotransmitter that acts at synapses through binding to ligand-gated ion channels, the GABA receptors. Clustering of the GABA-A receptor chloride channel alters receptor pharmacology on the cell surface and reduced clustering of the GABA receptor is associated with anxiety. GABA-A interacts with several proteins that modulate its clustering, endocytosis, and recycling or degradation. Plic-1 is a ubiquitin-like protein that binds to GABA-A receptors and causes them to accumulate at inhibitory synapses. Gephyrin interacts with the cytoplasmic domain of GABA-A, and with microtubules, bringing receptors together in plasma microdomains. Curiously, Gephyrin appears to be a bifunctional protein, with a domain involved in molybdenum metabolism. Another protein interacting with the GABA-A receptor is GABARAP, a microtubule-associated protein. Anchoring of the GABA-A receptor to GABARAP helps to cluster the receptor at the synaptic termini and to mediate fast synaptic transmission. GABARAP may mediate interaction of gephyrin with the GABA-A receptor and gephyrin may stabilize clusters by forming multimeric structures. GABARAP and gephyrin may play more of a role in receptor sorting and transport to the cell surface than in anchoring to the cytoplasm, since at inhibitory synapses GABARAP appears to associated with transport vesicles rather than the cell surface. The association of GABARAP with NSF (N-ethyl maleimide sensitive factor), a protein involved in intracellular vesicle transport, supports this hypothesis.
Contributor: Kosi Gramatikoff, PhD
REFERENCES: Bedford FK, Kittler JT, Muller E, Thomas P, Uren JM, Merlo D, Wisden W, Triller A, Smart TG, Moss SJ. GABA(A) receptor cell surface number and subunit stability are regulated by the ubiquitin-like protein Plic-1. Nat Neurosci 2001 Sep;4(9):908-16 Chen L, Wang H, Vicini S, Olsen RW. The gamma-aminobutyric acid type A (GABAA) receptor-associated protein (GABARAP) promotes GABAA receptor clustering and modulates the channel kinetics. Proc Natl Acad Sci U S A. 2000 Oct 10;97(21):11557-62. Coyle JE, Qamar S, Rajashankar KR, Nikolov DB.Structure of GABARAP in two conformations: implications for GABA(A) receptor localization and tubulin binding.Neuron. 2002 Jan 3;33(1):63-74. Crestani F, Lorez M, Baer K, Essrich C, Benke D, Laurent JP, Belzung C, Fritschy JM, Luscher B, Mohler H. Decreased GABAA-receptor clustering results in enhanced anxiety and a bias for threat cues. Nat Neurosci 1999 Sep;2(9):833-9 Kittler JT, Rostaing P, Schiavo G, Fritschy JM, Olsen R, Triller A, Moss SJ. The subcellular distribution of GABARAP and its ability to interact with NSF suggest a role for this protein in the intracellular transport of GABA(A) receptors. Mol Cell Neurosci 2001 Jul;18(1):13-25 Kittler JT, Rostaing P, Schiavo G, Fritschy JM, Olsen R, Triller A, Moss SJ. The subcellular distribution of GABARAP and its ability to interact with NSF suggest a role for this protein in the intracellular transport of GABA(A) receptors. Mol Cell Neurosci. 2001 Jul;18(1):13-25. Kneussel M, Haverkamp S, Fuhrmann JC, Wang H, Wassle H, Olsen RW, Betz H. The gamma-aminobutyric acid type A receptor (GABAAR)-associated protein GABARAP interacts with gephyrin but is not involved in receptor anchoring at the synapse. Proc Natl Acad Sci U S A 2000 Jul 18;97(15):8594-9 Kneussel M, Haverkamp S, Fuhrmann JC, Wang H, Wassle H, Olsen RW, Betz H. The gamma-aminobutyric acid type A receptor (GABAAR)-associated protein GABARAP interacts with gephyrin but is not involved in receptor anchoring at the synapse. Proc Natl Acad Sci U S A. 2000 Jul 18;97(15):8594-9. Luscher B, Keller CA.Ubiquitination, proteasomes and GABA(A) receptors. Nat Cell Biol. 2001 Oct;3(10):E232-3. No abstract available. May AP, Whiteheart SW, Weis WI. Unraveling the mechanism of the vesicle transport ATPase NSF, the N-ethylmaleimide-sensitive factor. J Biol Chem. 2001 Jun 22;276(25):21991-4. Review. No abstract available. Ramming M, Kins S, Werner N, Hermann A, Betz H, Kirsch J. Diversity and phylogeny of gephyrin: tissue-specific splice variants, gene structure, and sequence similarities to molybdenum cofactor-synthesizing and cytoskeleton-associated proteins. Proc Natl Acad Sci U S A. 2000 Aug 29;97(18):10266-71. Stangler T, Mayr LM, Willbold D. Solution structure of human GABA(A) receptor-associated protein GABARAP: implications for biolgoical funcrion and its regulation. J Biol Chem. 2002 Apr 19;277(16):13363-6. Wang H, Bedford FK, Brandon NJ, Moss SJ, Olsen RW. GABA(A)-receptor-associated protein links GABA(A) receptors and the cytoskeleton. Nature 1999 Jan 7;397(6714):69-72
醫療科技公司CarisLifeSciences(CAI.US)于美東時間周三登陸納斯達克市場,在美股首次公開募股(IPO)中籌資4.94億美元,發行價高于原定區間上限。該股一經上市便高漲至近40%,周......
2025年5月30日,中國科學院分子植物科學卓越創新中心詹帥研究團隊在國際學術期刊Science發表了題為“FunctionalpolymorphismofCYCLEunderliesdiapause......
干細胞是再生醫學最著名的例子 肝病的新療法是東京醫科大學的TakahiroOchiya的目標,他與EviaLifeSciences合作,EviaLifeSciences是一家由OctaveV......
AHA2018年會上公布的一項3期研究結果顯示,對于不能耐受他汀類藥物的高膽固醇血癥患者,新型藥物Bempedoicacid治療可能是一種降低LDL水平的安全有效的方法。德國萊比錫大學的心臟病學專家U......
2015年1月12日-15日,第33屆JP摩根健康投融資大會在美國舊金山舉行。大會上,各家公司都派出重量級陣營,公布上年度經營業績,發布最新產品。賽默飛世爾科技收購LifeTech的大約一年后,公司總......
近日,ThermoFisher公司宣布他們旗下子公司LifeTech高通量測序系統IonPGMDx獲歐洲CE標示,這也就意味著IonPGMDx系統獲得了進入歐洲市場的許可。歐盟CE標志是安全合格標志而......
2013年4月15號,LifeTechnologies與賽默飛(ThermoFisher)共同宣布了136億美元的交易。從此,LifeTech成為賽默飛生命科學部。兩個瘋狂的并購者終于撞到一起了。賽默......
2013年4月15日迅,賽默飛世爾科技于本周一(4月15日)以136億美元的收購價格,與LifeTechnologies公司最終達成收購協議。此項收購也將使得賽默飛在基因測序領域成為熱點關注的廠商之一......
2013年4月14日訊,據業內之情人士透露,賽默飛世爾科技將以接近130億美元的價格,與基因檢測設備制造商LifeTechnologies公司達成收購協議,這也將成為今年最大的企業并購案,雙方于周一(......
據業內知情人透露,賽默飛世爾科技在本周以每股65-70美元的價格,參與競購市值110億美元的生物醫學實驗室設備制造商LifeTechnologies公司。市值超過110億美元的LifeTech公司由于......